Watch the webinar “Importance of good nutrition and healthy diet for young myeloma patients”Myeloma, Videos18 October 2024
During European Myeloma Day, MPE highlights the importance of improving access to clinical trialsAccess, MPE, Myeloma27 September 2024
EMA recommends a new indication for daratumumab in adult patients with newly diagnosed myeloma who are eligible for autologous stem cell transplantAccess, Myeloma26 September 2024
A second bispecific antibody is approved as a fourth-line treatment for myeloma in England and WalesAccess, Myeloma, News17 July 2024
The National Institute for Health and Care Excellence (NICE) approves the use of elranatamab as a fourth-line treatment for myeloma in England and WalesAccess, Myeloma9 July 2024
European Commission approves CAR T-cell therapy ciltacabtagene autoleucel in earlier lines of therapy for relapsed and refractory myelomaAccess, CAR-T, Myeloma23 April 2024
MPE launches the Myeloma and AL Amyloidosis European Clinical Trial NavigatorAccess, AL amyloidosis, MPE, Myeloma23 April 2024
Q&A: US Food and Drug Administration (FDA) approves MRD as a basis for accelerated approval in myelomaAccess, MPE, Myeloma18 April 2024
Snežana Doder, young myeloma patient: “When I talk about my journey, I compare it to a roller coaster. Everything happened very fast and unexpectedly”MPE, Myeloma25 March 2024
